The Clinical Benefit Of Pegylated Liposomal Doxorubicin In Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial
S-E Al-Batran, J Bischoff, G von Minckwitz, A Atmaca, U Kleeberg, I Meuthen, G Morack, W Lerbs, D Hecker, J Sehouli, A Knuth, E Jager